Summary
The β3-adrenoreceptor (β3-AR) has been shown to mediate various pharmacological and physiological effects such as lipolysis, thermogenesis, and intestinal smooth muscle relaxation. It also plays an important role in glucose homeostasis and energy balance. Molecular modeling studies were undertaken to develop predictive pharmacophoric hypothesis and 3D-QSAR model, which may explain variations in β3-AR agonistic activity in terms of chemical features and physicochemical properties. The two softwares, CATALYST for pharmacophoric alignment and APEX-3D for 3D-QSAR modeling were used to establish the structure activity relationships for β3-AR agonistic activity. Among the several statistically significant models, the selection of the best pharmacophore and 3D-QSAR model was based on its ability to estimate the activity of external test sets of similar and different structural types along with the reasonable consistency of the model with the limited information of the active site of β3-AR. The final 3D-QSAR model was derived using the pharmacophoric alignments from the hypothesis which consisted of four chemical features: basic or positive ionizable feature on the nitrogen of the aryloxypropylamino group, two ring aromatic features corresponding to the phenyl ring of the phenoxide and the benzenesulphonamido groups and a hydrogen-bond donor (HBD) in the vicinity of the nitrogen atom of the benzenesulphonamido group with the most active molecule map** in an energetically favorable extended conformation. This hypothesis was in agreement with the site directed mutagenesis studies on human β3-AR and correlated well the observed and estimated activity both in, training and both the external test sets. It also mapped reasonably well to six β3-AR agonists of different structural classes under clinical development and thus this hypothesis may have a universal applicability in providing a powerful template for virtual screening and also for designing new chemical entities (NCEs) as β3-AR agonists.
Similar content being viewed by others
References
R.J. Mathvink J.S. Tolman D. Chitty M.R. Candelore M.A. Cascieri L.F. Colwell SuffixJr. L. Deng W.P. Feeney M.J. Forrest G.J. Hom D.E. MacIntyre R.R. Miller R.A. Stearns L. Tota M.J. Wyvratt M.H. Fisher Weber (2000) J. Med. Chem. 43 3832 Occurrence Handle10.1021/jm000286i Occurrence Handle11052788
Y. He V.I. Nikulin S.S. Vansal D.R. Feller D.D. Miller (2000) J. Med. Chem. 43 591 Occurrence Handle10.1021/jm990463j Occurrence Handle1:CAS:528:DC%2BD3cXotlOgtw%3D%3D Occurrence Handle10691685
W. Zheng V.I. Nikulin A.A. Konkar S.S. Vansal G. Shams D.R. Feller D.D. Miller (1999) J. Med. Chem., 42 2287
B. Hu J. Ellingboe S. Han E. Largis R. Mulvey A. Oliphant F.W.J. Sum Tillett (2001) J. Med. Chem., 44 1456
D.E. Uehling K.H. Donaldson D.N. Deaton C.E. Hyman E.E. Sugg D.G. Barrett R.G. Hughes B. Reitter K.K. Adkison M.E. Lancaster F. Lee R. Hart M.A. Paulik B.W. Sherman T. True C. Cowan (2002) J. Med. Chem. 45 567 Occurrence Handle10.1021/jm0101500 Occurrence Handle1:CAS:528:DC%2BD3MXptlKisbw%3D Occurrence Handle11806709
L.L. Brockunier M.R. Candelore M.A. Cascieri Y. Liu L. Tota M.J. Wyvratt M.H. Fisher A.E. Weber E.R. Parmee (2001) Bioorg. Med. Chem. Lett. 11 379 Occurrence Handle10.1016/S0960-894X(00)00669-7 Occurrence Handle1:CAS:528:DC%2BD3MXhtFylsLs%3D Occurrence Handle11212115
H.O. Ok L.B. Reigle M.R. Candelore M.A. Cascieri L.F. Colwell L. Deng W.P. Feeney M.J. Forrest G.J. Hom D.E. MacIntyre C.D. Strader L. Tota P. Wang M.J. Wyvratt M.H. Fisher A.E. Weber (2000) Bioorg. Med. Chem. Lett. 10 1531 Occurrence Handle10.1016/S0960-894X(00)00277-8 Occurrence Handle1:CAS:528:DC%2BD3cXkvFKisr8%3D Occurrence Handle10915043
D.D. Feng T. Biftu M.R. Candelore M.A. Cascieri L.F. Colwell SuffixJr. L. Deng W.P. Feeney M.J. Forrest G.J. Hom D.E. MacIntyre R.R. Miller R.A. Stearns C.D. Strader L. Tota M.J. Wyvratt M.H. Fisher A.E. Weber (2000) Bioorg. Med. Chem. Lett. 10 1427 Occurrence Handle10.1016/S0960-894X(00)00267-5 Occurrence Handle1:CAS:528:DC%2BD3cXksFynurg%3D Occurrence Handle10888324
E.R. Parmee L.L. Brockunier J. He S.B. Singh M.R. Candelore M.A. Cascieri L. Deng Y. Liu L. Tota M.J Wyvratt M.H. Fisher A.E. Weber (2000) Bioorg. Med. Chem. Lett. 10 2283 Occurrence Handle10.1016/S0960-894X(00)00459-5 Occurrence Handle1:CAS:528:DC%2BD3cXntF2lu7k%3D Occurrence Handle11055339
R.J. Steffan M.A. Ashwell W.R. Solvibile E. Matelan E. Largis S. Han J. Tillet R. Mulvey (2002) Bioorg. Med. Chem. Lett. 12 2957 Occurrence Handle10.1016/S0960-894X(02)00607-8 Occurrence Handle1:CAS:528:DC%2BD38Xntlagurc%3D Occurrence Handle12270183
A.E. Weber R.J. Mathvink L. Perkins J.E. Hutchins M.R. Candelore L. Tota C.D. Strader M.J. Wyvratt M.H. Fisher (1998) Bioorg. Med. Chem. Lett. 8 1110
E.R. Parmee H.O. Ok M.R. Candelore L. Tota L. Deng C.D. Stander M.J. Wyvaratt M.H. Fisher A.E. Weber (1998) Bioorg. Med. Chem. Lett. 8 1107 Occurrence Handle10.1016/S0960-894X(98)00170-X Occurrence Handle1:CAS:528:DyaK1cXjtlSnur4%3D Occurrence Handle9871717
R.J. Mathvink A.M. Barritta M.R. Candelore M.A. Cascieri L. Deng L. Tota C.D. Strader M.J. Wyvratt M.H. Fisher A.E. Weber (1999) Bioorg. Med Chem Lett. 9 1869 Occurrence Handle10.1016/S0960-894X(99)00277-2 Occurrence Handle1:CAS:528:DyaK1MXkt12hurY%3D Occurrence Handle10406657
(a) Steffan, R.J., Ashwell, M.A., Solvibile, W.R., Matelan, E., Largis, E., Han, S., Tillet, J. and Mulvey, R., Bioorg. Med. Chem. Lett., 12 (2002) 2957. (b) Berkowitz, D.E., Nardone, N.A., Smiley, R.M., Price, D.T., Kreutter, D.K. and Fremeau, R.T., Eur. J. Pharmacol., 289 (1995) 223
K. Clement C. Vaisse B.S.J. Mannings A. Basdevant B. Guy-Grand J. Ruis (1995) N. Engl. J. Med. 333 352 Occurrence Handle10.1056/NEJM199508103330605 Occurrence Handle1:CAS:528:DyaK2MXnvValsL0%3D Occurrence Handle7609752
Himms-Hagen, J., In Obesity, V., Johrporp, P. and Bordoll, B.N., Eds., Lippin Cott, Philadelphia, 1992, 15,␣2
J.R.S. Arch A.T. Aimsworth M.A. Cawthorme V. Piercy M.V. Sennitt V.A. Thody C. Wilson S. Wilson (1984) Nature 309 163 Occurrence Handle10.1038/309163a0 Occurrence Handle1:CAS:528:DyaL2cXktFOitrw%3D Occurrence Handle6325935
R.L. Dow (1997) Exp. Opin. Invest. Drugs. 6 1811 Occurrence Handle10.1517/13543784.6.12.1811 Occurrence Handle1:CAS:528:DyaK2sXnvFGntr4%3D
A.D. Strosberg (1997) Trends Pharmacol. Sci. 18 449 Occurrence Handle1:CAS:528:DyaK1cXlt1Oksg%3D%3D Occurrence Handle9458691
J.R.S. Arch S. Wilson (1996) Int. J. Obes. 20 191 Occurrence Handle1:CAS:528:DyaK28**sVCisb8%3D
N. Sakane T. Yoshida K. Yoshioka Y. Nakamura T. Umekawa A. Kogure Y. Takakura M. Kondo (1998) Diabetologia. 41 1533 Occurrence Handle10.1007/s001250051103 Occurrence Handle1:STN:280:DyaK1M%2FotlWisQ%3D%3D Occurrence Handle9867224
M. Ghorbani T.H. Claus J. Himms-Hagen (1997) Biochem. Pharmacol. 54 21 Occurrence Handle10.1016/S0006-2952(97)00162-7
A. Anthony S. Schepelmann J.L. Guillaume A.D. Strosberg A.P. Dhillon R.E. Pounder A.J. Wakefield (1998) Aliment Pharmacol. Ther. 12 519 Occurrence Handle10.1046/j.1365-2036.1998.00345.x Occurrence Handle1:CAS:528:DyaK1cXksVSntr8%3D Occurrence Handle9678810
C. Gauthier G. Tavernier F. Charpentier D. Langin H. Le Marec (1996) J. Clin. Invest. 98 556 Occurrence Handle1:CAS:528:DyaK28XksFClt7g%3D Occurrence Handle8755668
S.T. Russell K. Hirai M.J. Tisdale (2002) Br. J. Cancer. 86 424 Occurrence Handle10.1038/sj.bjc.6600086 Occurrence Handle1:CAS:528:DC%2BD38**sFOls7o%3D Occurrence Handle11875710
Y. Igawa Y. Yamazaki H. Takeda K. Hayakawa M. Akahane Y. Ajisawa T. Yoneyama O. Nishizawa K.E Andersson (1999) Br. J. Pharmacol. 126 819 Occurrence Handle10.1038/sj.bjp.0702358 Occurrence Handle1:CAS:528:DyaK1MXhslWitb4%3D Occurrence Handle10188996
Y. Igawa Y. Yamazaki H. Takeda K. Hayakawa M. Akahane Y. Ajisawa T. Yoneyama O. Nishizawa K.E. Andersson (2001) J. Urol. 165 240 Occurrence Handle10.1097/00005392-200101000-00071 Occurrence Handle1:STN:280:DC%2BD3M%2FovFWqsQ%3D%3D Occurrence Handle11125417
N. Tanaka T. Tamai H. Mukaiyama A. Hirabayashi H. Muranaka S. Akahane H. Miyata M. Akahane (2001) J. Med. Chem. 44 1436 Occurrence Handle10.1021/jm000455z Occurrence Handle1:CAS:528:DC%2BD3M**tlCmsLg%3D Occurrence Handle11311067
J. Gros B.S. Manning F. Pietri-Rouxel J.L. Guillaume M.F. Drumare A.D. Strosberg (1998) Eur. J. Biochem. 251 590 Occurrence Handle10.1046/j.1432-1327.1998.2510590.x Occurrence Handle1:CAS:528:DyaK1cXhtVKktb0%3D Occurrence Handle9490030
M.D. Amici C.D. Micheli L. Kassi G. Carrea G. Ottolina G. Colombo (2001) Tetrahedron 9 1849 Occurrence Handle10.1016/S0040-4020(00)01165-0
X.M. Guan A. Amend C.D. Strader (1995) Mol. Pharmacol. 48 492 Occurrence Handle1:CAS:528:DyaK2MXosVKgsr0%3D Occurrence Handle7565630
K.E. Furse T.P. Lybrand (2003) J. Med. Chem. 46 4450 Occurrence Handle10.1021/jm0301437 Occurrence Handle1:CAS:528:DC%2BD3sXnvVCjtbw%3D Occurrence Handle14521408
T. Nagatomo K. Koike (2000) Life Sci. 66 2419 Occurrence Handle1:CAS:528:DC%2BD3cXjtlOgs70%3D Occurrence Handle10894084
Y. Patel V.J. Gillet G. Bravi A.R. Leach (2002) J.␣Comput. Aided Mol. Des. 16 653 Occurrence Handle10.1023/A:1021954728347 Occurrence Handle1:CAS:528:DC%2BD3s**slKgtQ%3D%3D Occurrence Handle12602956
CATALYST Version 4.6, Accerlys, San Diego, CA
A.K. Debnath (2003) J. Med. Chem. 46 4501 Occurrence Handle10.1021/jm030265z Occurrence Handle1:CAS:528:DC%2BD3sXnt1Omsbo%3D Occurrence Handle14521412
O.O. Clement C.M. Freeman R.W. Hartmann V.D. Handratta T.S. Vasaitis A.M. Brodie V.C. Njar (2003) J.␣Med. Chem. 46 2345 Occurrence Handle10.1021/jm020576u Occurrence Handle1:CAS:528:DC%2BD3sXjs12ksL8%3D Occurrence Handle12773039
M.L. Barreca R. Gitto S. Quartarone L. Luca ParticleDe G. Sarro ParticleDe A. Chimirri (2003) J. Chem. Inf. Comput. Sci. 43 651 Occurrence Handle10.1021/ci025625q Occurrence Handle1:CAS:528:DC%2BD3sXnt1ShsQ%3D%3D Occurrence Handle12653534
A. Palomer F. Cabre J. Pascual J. Campos M.A. Trujillo A. Entrena M.A. Gallo L. Garcia D. Mauleon Espinosa (2002) J. Med. Chem. 45 1402 Occurrence Handle10.1021/jm010458r Occurrence Handle1:CAS:528:DC%2BD38XhsVGjsbY%3D Occurrence Handle11906281
A.K. Debnath (2002) J. Med. Chem. 45 41 Occurrence Handle10.1021/jm010360c Occurrence Handle1:CAS:528:DC%2BD3MXptlSrs7g%3D Occurrence Handle11754578
P. Kraft J.A. Bajgrowicz C. Denis G. Frater (2000) Angew. Chem. Int. Ed. 39 2980 Occurrence Handle10.1002/1521-3773(20000901)39:17<2980::AID-ANIE2980>3.0.CO;2-# Occurrence Handle1:CAS:528:DC%2BD3cXmsFWgtLs%3D
http://www.accelrys.com/references/rdd_pub.html(CATALYST
Golender, V.E. and Rozenblit, A.B. (1983) Logical and Combinatorial Algorithms in Drug Design, Research Studies Press: Letchworth, UK, Golender, V.E., Vorpagel E.R. In: 3D QSAR in Drug Design: Theory, Methods and Applications, Kubinyi H. (Ed), ESCOM, Leiden, 1993, 137–149
Y.C. Martin M.G. Bures E.A. Danaher J. DeLazzer I.P.A. Lico Pavlik (1993) J. Comput. Aided Mol. Des. 7 83 Occurrence Handle10.1007/BF00141577 Occurrence Handle1:CAS:528:DyaK3sXksVSht7s%3D Occurrence Handle8097240
Norinder U. (1995) The Alignment problem in 3D-QSAR: A combined approach using CATALYST and a 3D-QSAR technique, QSAR and Molecular Modelling: Concepts, Computational Tools and Biological Applications In Sanz, F. Giraldo, J., Manaut F. (Eds.), Prous Science Publishers, Barcelona, pp. 433–438
R.D. Hoffmann T. Langer (1995) NoChapterTitle Sanz F. Giraldo J.F. Manaut (Eds) Use of the CATALYST program as a new alignment tool for 3D-QSAR”, QSAR and Molecular Modelling: Concepts, Computational Tools and Biological Applications Prous Science Publishers Barcelona 466–469
T. Langer R.D. Hoffmann (1998) J. Chem. Inf. Comput. Sci. 38 325 Occurrence Handle10.1021/ci970448s Occurrence Handle1:CAS:528:DyaK1cXhvVWhsr4%3D
A. Palomer J. Pascual F. Cabré M.L. García D. Mauleón (2000) J. Med. Chem. 43 392 Occurrence Handle10.1021/jm990387k Occurrence Handle1:CAS:528:DC%2BD3cXksVSksg%3D%3D Occurrence Handle10669566
R. Bureau C. Daveu I. Baglin J. Sopkova-De Olivera Santos J.-C. Lancelot S. Rault (2001) J. Chem. Inf. Comput. Sci. 41 815 Occurrence Handle10.1021/ci000058x Occurrence Handle1:CAS:528:DC%2BD3M**vFCjsLY%3D Occurrence Handle11410063
A. Golbraikh A. Tropsha (2002) J. Mol. Graphics Model. 20 269 Occurrence Handle10.1016/S1093-3263(01)00123-1 Occurrence Handle1:CAS:528:DC%2BD3MXpt1art7o%3D
Wold S., Martens, H., Wold, H. (1983) In Ruhe, A., Agstrom B.K (Eds.), Springer Verlag, Heidelberg
S. Wold (1978) Technometrics 20 397
A.K.P. Saxena Prathipati (2003) SAR and QSAR Environ. Res. 14 433 Occurrence Handle10.1080/10629360310001624015
P.W. Sprague (1995) Automated chemical hypothesis generation and database searching with CATALYST K. Muller (Eds) perspectives in Drug Discovery and Design ESCOM: Leiden 1–20
Apex-3D version 1.4 user guide, Biosym MSI, San Diego, Sept. 1993
T. Pandya S.K. Pandey M. Tiwari S.C. Chaturvedi A.K. Saxena (2001) Bioorg. Med. Chem. 9 291 Occurrence Handle10.1016/S0968-0896(00)00243-1 Occurrence Handle1:CAS:528:DC%2BD3MXhs1artb0%3D Occurrence Handle11249122
A.K. Saxena S.K. Pandey P. Seth M.P. Singh M. A. Dikshit Carpy (2001) Bioorg. Med. Chem. 9 2025 Occurrence Handle10.1016/S0968-0896(01)00082-7 Occurrence Handle1:CAS:528:DC%2BD3MXlvFWiurs%3D Occurrence Handle11504639
S.K. Pandey N.B. Naware P. Trivedi A.K. Saxena (2001) SAR and QSAR Envir. Res. 12 547 Occurrence Handle1:CAS:528:DC%2BD38XkvFSmsw%3D%3D
M.A. Babu N. Shakya P. Prathipati S.G. Kaskhedikar A.K. Saxena (2002) Bioorg. Med. Chem. 10 4035 Occurrence Handle10.1016/S0968-0896(02)00313-9 Occurrence Handle12413856
A.K. Saxena S.K. Pandey R.C. Tripathi R Raghubir. (2001) Bioorg. Med. Chem. 9 1559 Occurrence Handle10.1016/S0968-0896(01)00042-6 Occurrence Handle1:CAS:528:DC%2BD3MXkt1Kjsb8%3D Occurrence Handle11408175
S.K. Kashaw L. Rathi P. Mishra A.K. Saxena (2003) Bioorg. Med. Chem. Lett. 13 2481 Occurrence Handle10.1016/S0960-894X(03)00491-8 Occurrence Handle1:CAS:528:DC%2BD3sXlt1WgsLw%3D Occurrence Handle12852947
L. Rathi S.K. Kashaw A Dixit G Pandey P. Mishra A.K. Saxena (2004) Bioorg. Med. Chem. 1 1
B.R. Brooks R.E. Bruccoleri B.D. Olafson D.J. States S. Swaminathan A.M. Karplus (1983) J. Comp. Chem. 4 187 Occurrence Handle10.1002/jcc.540040211 Occurrence Handle1:CAS:528:DyaL3s**t1aiu7w%3D
K. Gundertofte T. Liljefors P-O Norrby I. Pattesson (1996) J Comp. Chem. 17 429 Occurrence Handle10.1002/(SICI)1096-987X(199603)17:4<429::AID-JCC5>3.0.CO;2-W Occurrence Handle1:CAS:528:DyaK28XhtVylt7o%3D
J. Bostrom (2001) J. Comput. Aided Mol. Des. 12 1137 Occurrence Handle10.1023/A:1015930826903
A.S. Smellie S.D. Kahm S.L. Teig (1995) J. Chem. Inf. Comput. Sci. 35 285 Occurrence Handle10.1021/ci00024a018 Occurrence Handle1:CAS:528:DyaK2MXktleksr4%3D
A.S. Smellie S.L. Teig S.D. Kahm (1995) J. Chem. Inf. Comput. Sci. 35 295 Occurrence Handle10.1021/ci00024a019 Occurrence Handle1:CAS:528:DyaK2MXktleksr8%3D
J. Greene S. Kahn H. Savoj P. Sprague S. Teig (1994) J.␣Chem. Inf. Comput Sci. 34 1297 Occurrence Handle10.1021/ci00022a012 Occurrence Handle1:CAS:528:DyaK2cXmsFCrurg%3D
Sutter, J., Guner, O., Hoffman, R., Li, H. and Waldman, M., Effect of Variable Weights and Tolerances on Predictive Model Generation, in Pharmacophore Perception, Development, and Use in Drug Design, O.F. Guner, Ed., International University Line, La Jolla, CA, 2000
P. Dauber-Osguthorpe V.A. Roberts D.J. Osguthorpe J. Wolff M. Genest A.T. Hagler (1988) ArticleTitleProteins: Struct. Funct Genet 4 31 Occurrence Handle1:CAS:528:DyaL1M**tVegsw%3D%3D
P. Hobza M. Kabelac J. Sponer P. Mejzlik J. Vondrasek (2000) J. Comp. Chem. 18 1136 Occurrence Handle10.1002/(SICI)1096-987X(19970715)18:9<1136::AID-JCC3>3.0.CO;2-S
C. Weyer C.J Souza Particlede (2000) Drug Dev. Res. 51 80 Occurrence Handle10.1002/1098-2299(200010)51:2<80::AID-DDR4>3.0.CO;2-E Occurrence Handle1:CAS:528:DC%2BD3M**t1CjsQ%3D%3D
C.J. Souza Particlede M.F. Hirshman E.S. Horton (1997) Diabetes 46 1257 Occurrence Handle9231648
T.L. Shih M.R. Candelore M.A. Cascieri S.H. Chiu L.F Colwell SuffixJr. L. Deng W.P. Feeney M.J. Forrest G.J. Hom D.E. MacIntyre R.R. Miller R.A. Stearns C.D. ␣Strader L. Tota M.J. Wyvratt M.H. Fisher A.E. Weber (1999) Bioorg Med. Chem. Lett. 9 1251 Occurrence Handle10.1016/S0960-894X(99)00182-1 Occurrence Handle10340609
E.R. Parmee E.M. Naylor L. Perkins V.J. Colandrea H.O. Ok M.R. Candelore M.A. Cascieri L. Deng W.P. Feeney M.J. Forrest G.J. Hom D.E. MacIntyre R.R. Miller R.A. Stearns C.D. Strader L. Tota M.J. Wyvratt M.H. Fisher A.E. Weber (1999) Bioorg. Med. Chem. Lett. 9 749 Occurrence Handle10.1016/S0960-894X(99)00073-6 Occurrence Handle1:CAS:528:DyaK1MXhvFehsro%3D Occurrence Handle10201841
Dianippon Pharma Co. 1998. AJ-9677: β3-adrenoceptor agonist. Pharmacological study report Ed. #1 (non-confidential information). Research and Development Headquarters.; Kawashima, H., Nomura, A., Ohue, M., Kato, H., Kuwajima, J., Furutani, Y., Hosoki, K., Diabetologia, 40 (1997) A374
D.M. Hargrove R.L. Dow K.A. Martin N.A. Nardone S.J. Orena A.M. Brodeur A.J. Torchia D.K. Kreutter S. Yee R.W. Stevenson (1999) Obes Res. 7 72S
J.W. Miller N.A. Farid R.D. Johnson B.P. Smith J. Dananberg (1999) Obes. Res. 7 121S
T.-L. Lee C.-T. Hsu S.-T. Yen C.-W. Lai J.-T. Cheng (1998) J. Auton. Nerv. Sys. 11 86 Occurrence Handle10.1016/S0165-1838(98)00120-9 Occurrence Handle1:STN:280:DyaK1c7kvVCmug%3D%3D
N. Blin L. Camoin B. Maigret A.D. Strosberg (1994) Mol. Phar. 44 1094–1104
Author information
Authors and Affiliations
Additional information
★CDRI communication number 6202.
*To whom correspondence should be addressed. Fax: +91-0522-223405; E-mail: anilsak@hotmail.com
Rights and permissions
About this article
Cite this article
Prathipati, P., Saxena, A.K. Characterization of β3-adrenergic receptor: determination of pharmacophore and 3D QSAR model for β3 adrenergic receptor agonism. J Comput Aided Mol Des 19, 93–110 (2005). https://doi.org/10.1007/s10822-005-1558-7
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10822-005-1558-7